key: cord-0876868-k4vrpzrz
authors: Franco-Moreno, A.; Piniella-Ruiz, E.; Montoya-Adarraga, J.; Ballano-Franco, C.; Alvarez-Miguel, F.; Peinado-Martinez, C.; Landete-Hernandez, E.; Saez-Vaquero, T.; Ulla-Anes, M.; Torres-Macho, J.
title: Portal vein thrombosis in a patient with COVID-19
date: 2020-06-13
journal: Thromb Res
DOI: 10.1016/j.thromres.2020.06.019
sha: ce9cadd8d7186cf7ad6ca534085987fc39f36b0f
doc_id: 876868
cord_uid: k4vrpzrz

nan

J o u r n a l P r e -p r o o f

A 27-year-old man from Dominican Republic, with no past medical or surgical history, presented to the emergency department in March 2020, with a three days history of severe colic abdominal pain without nausea, vomiting or diarrhoea. Three weeks before admission he had developed fever and dry cough. In the setting of the COVID-19 pandemic, during those three weeks the patient stayed home self-isolated, with analgesic and antipyretic treatment. In the emergency department, the patient's temperature was 38.8°C, he had sinus tachycardia with 150 beats per minute, blood pressure 100/75 mm Hg, respiratory rate 15 breaths per minute, and oxygen saturation 99% on room air. Physical examination showed an alert young man. Chest auscultation revealed bi-basal crackles. His abdomen was non-distended, with tenderness in the right upper quadrant with negative Murphy's sign. No masses or inguinal hernias were appreciated. No signs of deep vein thrombosis in the lower extremities were found on physical examination. Laboratory findings showed elevated serum aspartate aminotransferase 64 U/L, alanine aminotransferase 111 U/L, lactate dehydrogenase 253 U/L, alkaline phosphatase 148 U/L, total leukocyte count 18 × 10 9 /L (85% neutrophils and 8% lymphocytes), platelets 458 × 10 9 /l, serum fibrinogen > 500 mg/dL (normal range [RN] 150-400), D-dimer using Innovance ® D-dimer assay 9.530 μg/L (RN < 500) and C-reactive protein 245 mg/L, while total bilirubin, amylase, lipase, BUN, creatinine clearance, sodium, potassium, calcium, total red blood cell count, haemoglobin, haematocrit, international normalized ratio (INR), activated partial thromboplastin (aPTT) and prothrombin time (PT) were normal. The chest X-ray showed alveolo-interstitial opacities in both inferior lobes (Fig. 1a) . Therefore, a nasopharyngeal swab for SARS-CoV-2 was performed due to COVID-19 suspicion. A thoracoabdominal computed tomographic (TC) scan with intravenous iodine contrast confirmed

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Haemostasis and innate immunity -a complementary relationship: A review of the intricate relationship between coagulation and complement pathways

The versatile heparin in COVID-19

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia